RxNorm Semantic Concepts Index - 687
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "687".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 687 | Peptidase a | Designated preferred name (PT) | NO | |
| RxCUI: 687 | Peptidase a | Full form of descriptor (FN) | NO | |
| RxCUI: 687 | Peptidase a | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687020 | ALPRAZolam 3 MG [Xanax] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 687020 | ALPRAZolam 3 MG [Xanax] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 687021 | ALPRAZolam Extended Release Oral Tablet [Xanax] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 687021 | ALPRAZolam Extended Release Oral Tablet [Xanax] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 687022 | Xanax XR 3 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 687022 | Xanax XR 3 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 687022 | Xanax XR 3 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 687022 | Xanax XR 3 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 687022 | Xanax XR 3 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 687023 | Xanax XR 2 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 687023 | Xanax XR 2 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 687023 | Xanax XR 2 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 687023 | Xanax XR 2 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 687023 | Xanax XR 2 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 687024 | Xanax XR 1 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 687024 | Xanax XR 1 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 687024 | Xanax XR 1 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 687024 | Xanax XR 1 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 687024 | Xanax XR 1 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 687025 | Xanax XR 0.5 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 687025 | Xanax XR 0.5 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 687025 | Xanax XR 0.5 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 687025 | Xanax XR 0.5 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 687025 | Xanax XR 0.5 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 687039 | amphetamine aspartate 3.125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 687040 | amphetamine sulfate 3.125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 687041 | dextroamphetamine saccharate 3.125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 687042 | dextroamphetamine sulfate 3.125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 687043 | dextroamphetamine saccharate 3.125 MG / amphetamine aspartate 3.125 MG / dextroamphetamine sulfate 3.125 MG / amphetamine sulfate 3.125 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 687043 | dextroamphetamine saccharate 3.125 MG / amphetamine aspartate 3.125 MG / dextroamphetamine sulfate 3.125 MG / amphetamine sulfate 3.125 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 687043 | dextroamphetamine saccharate 3.125 MG / amphetamine aspartate 3.125 MG / dextroamphetamine sulfate 3.125 MG / amphetamine sulfate 3.125 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 687044 | amphetamine aspartate 3.125 MG / amphetamine sulfate 3.125 MG / dextroamphetamine saccharate 3.125 MG / dextroamphetamine sulfate 3.125 MG [Adderall] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 687045 | Adderall 12.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 687045 | Adderall 12.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 687045 | Adderall 12.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 687046 | fluvastatin 80 MG [Lescol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 687047 | fluvastatin Extended Release Oral Tablet [Lescol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 687048 | Lescol XL 80 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 687048 | Lescol XL 80 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 687048 | Lescol XL 80 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 687048 | Lescol XL 80 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 687057 | cadexomer iodine 0.009 MG/MG [Iodosorb] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 687058 | cadexomer iodine Topical Gel [Iodosorb] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 687059 | IODOSORB 0.9 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 687059 | IODOSORB 0.9 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 687059 | IODOSORB 0.9 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 687059 | IODOSORB 0.9 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 687063 | lamivudine / nevirapine / zidovudine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 687063 | lamivudine / nevirapine / zidovudine Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 687064 | lamiVUDine 150 MG / zidovudine 300 MG / nevirapine 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687064 | lamiVUDine 150 MG / zidovudine 300 MG / nevirapine 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 687064 | lamiVUDine 150 MG / zidovudine 300 MG / nevirapine 200 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 687064 | lamiVUDine 150 MG / zidovudine 300 MG / nevirapine 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 687064 | lamiVUDine 150 MG / zidovudine 300 MG / nevirapine 200 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 687064 | lamiVUDine 150 MG / zidovudine 300 MG / nevirapine 200 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 687066 | PHOTOFRIN 75 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 687066 | PHOTOFRIN 75 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 687066 | PHOTOFRIN 75 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 687068 | HCTZ 12.5 MG / Metoprolol 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687068 | HCTZ 12.5 MG / Metoprolol 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 687068 | HCTZ 12.5 MG / Metoprolol 25 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 687069 | HCTZ 12.5 MG / Metoprolol 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687069 | HCTZ 12.5 MG / Metoprolol 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 687069 | HCTZ 12.5 MG / Metoprolol 50 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 687078 | Aspirin- and paracetamol-containing product | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 687078 | Aspirin- and paracetamol-containing product | Designated preferred name (PT) | YES | |
| RxCUI: 687078 | Aspirin- and paracetamol-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 687078 | Aspirin- and paracetamol-containing product | Full form of descriptor (FN) | YES | |
| RxCUI: 687088 | Aminoacridine- and lidocaine-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 687088 | Aminoacridine- and lidocaine-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687088 | Aminoacridine- and lidocaine-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 687089 | Product containing antazoline and xylometazoline (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 687089 | Product containing antazoline and xylometazoline (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687089 | Product containing antazoline and xylometazoline (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687092 | Ascorbic acid- and paracetamol-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 687092 | Ascorbic acid- and paracetamol-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687092 | Ascorbic acid- and paracetamol-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 687094 | Avobenzone- and ecamsule- and octocrilene-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687094 | Avobenzone- and ecamsule- and octocrilene-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 687094 | Avobenzone- and ecamsule- and octocrilene-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 687096 | Product containing benzocaine and chloroxylenol (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 687096 | Product containing benzocaine and chloroxylenol (medicinal product) | Designated preferred name (PT) | YES | |
| RxCUI: 687096 | Product containing benzocaine and chloroxylenol (medicinal product) | Full form of descriptor (FN) | YES | |
| RxCUI: 687097 | polysaccharide iron complex 115.2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 687098 | ferrous fumarate / folic acid / polysaccharide iron complex Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 687099 | ferrous fumarate 162 MG / folic acid 1 MG / polysaccharide iron complex 115.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 687099 | ferrous fumarate 162 MG / folic acid 1 MG / polysaccharide iron complex 115.2 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 687099 | ferrous fumarate 162 MG / folic acid 1 MG / polysaccharide iron complex 115.2 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 687101 | ferrous fumarate / folic acid / polysaccharide iron complex Oral Capsule [Tandem F] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 687103 | Product containing benzocaine and cetylpyridinium (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 687103 | Product containing benzocaine and cetylpyridinium (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687103 | Product containing benzocaine and cetylpyridinium (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687104 | Product containing benzocaine and dequalinium (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 687104 | Product containing benzocaine and dequalinium (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687104 | Product containing benzocaine and dequalinium (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687108 | Product containing bimatoprost and timolol (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687108 | Product containing bimatoprost and timolol (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687112 | Product containing cade oil and coal tar (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687112 | Product containing cade oil and coal tar (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687113 | Product containing caffeine and glucose (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 687113 | Product containing caffeine and glucose (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687113 | Product containing caffeine and glucose (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687115 | Product containing calcium carbonate and opium (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687115 | Product containing calcium carbonate and opium (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687130 | Product containing cerium nitrate and silver sulfadiazine (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687130 | Product containing cerium nitrate and silver sulfadiazine (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687133 | Product containing cetalkonium and lidocaine (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687133 | Product containing cetalkonium and lidocaine (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687135 | Product containing chlorhexidine and nystatin (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687135 | Product containing chlorhexidine and nystatin (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687138 | Product containing chloroform and morphine (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687138 | Product containing chloroform and morphine (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687144 | Product containing clindamycin and tretinoin (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 687144 | Product containing clindamycin and tretinoin (medicinal product) | Designated preferred name (PT) | YES | |
| RxCUI: 687144 | Product containing clindamycin and tretinoin (medicinal product) | Full form of descriptor (FN) | YES | |
| RxCUI: 687147 | Product containing clove oil and lidocaine (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687147 | Product containing clove oil and lidocaine (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687148 | Product containing coal tar and lecithin (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 687148 | Product containing coal tar and lecithin (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687148 | Product containing coal tar and lecithin (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687192 | pyridostigmine Extended Release Oral Tablet [Mestinon] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 687192 | pyridostigmine Extended Release Oral Tablet [Mestinon] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 687195 | Allantoin- and coal tar extract-containing product | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 687195 | Allantoin- and coal tar extract-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 687195 | Allantoin- and coal tar extract-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 687196 | dextrose 3.3 % / sodium chloride 0.3 % Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687196 | dextrose 3.3 % / sodium chloride 0.3 % Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687196 | dextrose 3.3 % / sodium chloride 0.3 % Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 687198 | Aluminium hydroxide- and magnesium trisilicate-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 687198 | Aluminium hydroxide- and magnesium trisilicate-containing product | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 687198 | Aluminium hydroxide- and magnesium trisilicate-containing product | Designated preferred name (PT) | YES | |
| RxCUI: 687198 | Aluminium hydroxide- and magnesium trisilicate-containing product | Full form of descriptor (FN) | YES | |
| RxCUI: 687202 | metroNIDAZOLE 750 MG [Flagyl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 687202 | metroNIDAZOLE 750 MG [Flagyl] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 687203 | metroNIDAZOLE Extended Release Oral Tablet [Flagyl] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 687203 | metroNIDAZOLE Extended Release Oral Tablet [Flagyl] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 687204 | Flagyl ER 750 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 687204 | Flagyl ER 750 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 687204 | Flagyl ER 750 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 687204 | Flagyl ER 750 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 687204 | Flagyl ER 750 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 687209 | metroNIDAZOLE 375 MG [Flagyl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 687209 | metroNIDAZOLE 375 MG [Flagyl] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 687210 | metroNIDAZOLE Oral Capsule [Flagyl] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 687210 | metroNIDAZOLE Oral Capsule [Flagyl] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 687211 | Flagyl 375 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 687211 | Flagyl 375 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 687211 | Flagyl 375 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 687211 | Flagyl 375 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 687212 | Product containing aviptadil and phentolamine (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687212 | Product containing aviptadil and phentolamine (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687225 | Beclometasone- and salbutamol-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 687225 | Beclometasone- and salbutamol-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687225 | Beclometasone- and salbutamol-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 687227 | Bismuth biskalcitrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 687227 | Bismuth biskalcitrate | Designated preferred name (PT) | NO | |
| RxCUI: 687227 | Bismuth biskalcitrate | Full form of descriptor (FN) | NO | |
| RxCUI: 687227 | Bismuth biskalcitrate | Designated preferred name (PT) | NO | |
| RxCUI: 687227 | Bismuth biskalcitrate | Full form of descriptor (FN) | NO | |
| RxCUI: 687229 | bismuth biskalcitrate 140 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 687230 | bismuth biskalcitrate / metronidazole / tetracycline Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 687230 | bismuth biskalcitrate / metronidazole / tetracycline Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 687231 | bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline 125 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 687231 | bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline 125 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 687231 | bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline 125 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 687237 | Oxygen (15-O) butanol | Designated preferred name (PT) | NO | |
| RxCUI: 687237 | Oxygen (15-O) butanol | Full form of descriptor (FN) | NO | |
| RxCUI: 687237 | Oxygen (15-O) butanol | Designated preferred name (PT) | NO | |
| RxCUI: 687237 | Oxygen (15-O) butanol | Full form of descriptor (FN) | NO | |
| RxCUI: 68724 | I antigen | Designated preferred name (PT) | NO | |
| RxCUI: 68724 | I antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 68724 | I antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 68724 | I antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687244 | Product containing calcium lactate and calcium phosphate and ergocalciferol (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687244 | Product containing calcium lactate and calcium phosphate and ergocalciferol (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687252 | Product containing chlorobutanol and clove oil (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687252 | Product containing chlorobutanol and clove oil (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687254 | ciclesonide 0.05 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 687258 | Clioquinol- and flumetasone-containing product | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 687258 | Clioquinol- and flumetasone-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687258 | Clioquinol- and flumetasone-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 687258 | Clioquinol- and flumetasone-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 687259 | Product containing clioquinol and fluocinolone (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 687259 | Product containing clioquinol and fluocinolone (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687259 | Product containing clioquinol and fluocinolone (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687260 | Coal tar naphtha | Designated preferred name (PT) | NO | |
| RxCUI: 687260 | Coal tar naphtha | Full form of descriptor (FN) | NO | |
| RxCUI: 687262 | Conjugated estrogen- and norgestrel-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 687262 | Conjugated estrogen- and norgestrel-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 687271 | CYP2A13 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687271 | CYP2A13 | Designated preferred name (PT) | NO | |
| RxCUI: 687271 | CYP2A13 | Full form of descriptor (FN) | NO | |
| RxCUI: 687272 | CYP2A6 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687272 | CYP2A6 | Designated preferred name (PT) | NO | |
| RxCUI: 687272 | CYP2A6 | Full form of descriptor (FN) | NO | |
| RxCUI: 687274 | CYP2B6 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687274 | CYP2B6 | Designated preferred name (PT) | NO | |
| RxCUI: 687274 | CYP2B6 | Full form of descriptor (FN) | NO | |
| RxCUI: 687277 | CYP2C8 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687277 | CYP2C8 | Designated preferred name (PT) | NO | |
| RxCUI: 687277 | CYP2C8 | Full form of descriptor (FN) | NO | |
| RxCUI: 687278 | CYP2C9 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687278 | CYP2C9 | Designated preferred name (PT) | NO | |
| RxCUI: 687278 | CYP2C9 | Full form of descriptor (FN) | NO | |
| RxCUI: 68728 | Niferex-150 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 687282 | CYP2R1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687282 | CYP2R1 | Designated preferred name (PT) | NO | |
| RxCUI: 687282 | CYP2R1 | Full form of descriptor (FN) | NO | |
| RxCUI: 687283 | CYP2S1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687283 | CYP2S1 | Designated preferred name (PT) | NO | |
| RxCUI: 687283 | CYP2S1 | Full form of descriptor (FN) | NO | |
| RxCUI: 68729 | Niferex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 687290 | CYP4A11 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687290 | CYP4A11 | Designated preferred name (PT) | NO | |
| RxCUI: 687290 | CYP4A11 | Full form of descriptor (FN) | NO | |
| RxCUI: 687291 | CYP4A22 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687291 | CYP4A22 | Designated preferred name (PT) | NO | |
| RxCUI: 687291 | CYP4A22 | Full form of descriptor (FN) | NO | |
| RxCUI: 687293 | CYP5A1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687293 | CYP5A1 | Designated preferred name (PT) | NO | |
| RxCUI: 687293 | CYP5A1 | Full form of descriptor (FN) | NO | |
| RxCUI: 6873 | Methylcellulose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 6873 | Methylcellulose | Designated preferred name (PT) | YES | |
| RxCUI: 6873 | Methylcellulose | Full form of descriptor (FN) | YES | |
| RxCUI: 6873 | Methylcellulose | Designated preferred name (PT) | YES | |
| RxCUI: 6873 | Methylcellulose | Full form of descriptor (FN) | YES | |
| RxCUI: 68730 | milbemycin oxime | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 687304 | Product containing dexamethasone and tramazoline (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 687304 | Product containing dexamethasone and tramazoline (medicinal product) | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 687304 | Product containing dexamethasone and tramazoline (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687304 | Product containing dexamethasone and tramazoline (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687306 | Product containing dextran 70 and hypromellose (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 687306 | Product containing dextran 70 and hypromellose (medicinal product) | Designated preferred name (PT) | YES | |
| RxCUI: 687306 | Product containing dextran 70 and hypromellose (medicinal product) | Full form of descriptor (FN) | YES | |
| RxCUI: 687310 | Dipeptidyl peptidase IV inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 687310 | Dipeptidyl peptidase IV inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 687310 | Dipeptidyl peptidase IV inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 687310 | Dipeptidyl peptidase IV inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 687315 | Product containing domiphen and lidocaine (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 687315 | Product containing domiphen and lidocaine (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687315 | Product containing domiphen and lidocaine (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687320 | EDTA gallium-68 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687320 | EDTA gallium-68 | Designated preferred name (PT) | NO | |
| RxCUI: 687320 | EDTA gallium-68 | Full form of descriptor (FN) | NO | |
| RxCUI: 687320 | EDTA gallium-68 | Designated preferred name (PT) | NO | |
| RxCUI: 687320 | EDTA gallium-68 | Full form of descriptor (FN) | NO | |
| RxCUI: 687323 | Adrenaline- and guanethidine-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687323 | Adrenaline- and guanethidine-containing product | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 687323 | Adrenaline- and guanethidine-containing product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 687323 | Adrenaline- and guanethidine-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 687323 | Adrenaline- and guanethidine-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 687333 | Product containing estradiol and levonorgestrel (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 687333 | Product containing estradiol and levonorgestrel (medicinal product) | Designated preferred name (PT) | YES | |
| RxCUI: 687333 | Product containing estradiol and levonorgestrel (medicinal product) | Full form of descriptor (FN) | YES | |
| RxCUI: 687335 | Product containing estradiol and norgestrel (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687335 | Product containing estradiol and norgestrel (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687337 | Ethanol- and glycine-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 687337 | Ethanol- and glycine-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 687342 | Product containing fenoterol and ipratropium (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687342 | Product containing fenoterol and ipratropium (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687351 | Product containing fluocinolone and neomycin (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 687351 | Product containing fluocinolone and neomycin (medicinal product) | Designated preferred name (PT) | YES | |
| RxCUI: 687351 | Product containing fluocinolone and neomycin (medicinal product) | Full form of descriptor (FN) | YES | |
| RxCUI: 687354 | Free glycerol | Designated preferred name (PT) | NO | |
| RxCUI: 687354 | Free glycerol | Full form of descriptor (FN) | NO | |
| RxCUI: 687360 | Product containing galactose and palmitic acid (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687360 | Product containing galactose and palmitic acid (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687363 | Glucose- and treacle-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 687363 | Glucose- and treacle-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687363 | Glucose- and treacle-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 687367 | Glycerol- and sucrose-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 687367 | Glycerol- and sucrose-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687367 | Glycerol- and sucrose-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 687370 | Product containing gramicidin and neomycin (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687370 | Product containing gramicidin and neomycin (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687378 | Substance with histone deacetylase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 687378 | Substance with histone deacetylase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 687378 | Substance with histone deacetylase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 687378 | Substance with histone deacetylase inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687378 | Substance with histone deacetylase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 687383 | Human rubella immunoglobulin | Designated preferred name (PT) | NO | |
| RxCUI: 687383 | Human rubella immunoglobulin | Full form of descriptor (FN) | NO | |
| RxCUI: 687386 | Product containing ibuprofen and levomenthol (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 687386 | Product containing ibuprofen and levomenthol (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687386 | Product containing ibuprofen and levomenthol (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687403 | Product containing iodine and isopropyl alcohol (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 687403 | Product containing iodine and isopropyl alcohol (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687403 | Product containing iodine and isopropyl alcohol (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687408 | Isometheptene- and paracetamol-containing product | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 687408 | Isometheptene- and paracetamol-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 687408 | Isometheptene- and paracetamol-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 687408 | Isometheptene- and paracetamol-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 687415 | Fluorobenzothiazole (18-F) | Designated preferred name (PT) | NO | |
| RxCUI: 687415 | Fluorobenzothiazole (18-F) | Full form of descriptor (FN) | NO | |
| RxCUI: 687415 | Fluorobenzothiazole (18-F) | Designated preferred name (PT) | NO | |
| RxCUI: 687415 | Fluorobenzothiazole (18-F) | Full form of descriptor (FN) | NO | |
| RxCUI: 687417 | Fluoromethane (18-F) | Designated preferred name (PT) | NO | |
| RxCUI: 687417 | Fluoromethane (18-F) | Full form of descriptor (FN) | NO | |
| RxCUI: 687417 | Fluoromethane (18-F) | Designated preferred name (PT) | NO | |
| RxCUI: 687417 | Fluoromethane (18-F) | Full form of descriptor (FN) | NO | |
| RxCUI: 687419 | Fluoromisonidazole (18-F) | Designated preferred name (PT) | NO | |
| RxCUI: 687419 | Fluoromisonidazole (18-F) | Full form of descriptor (FN) | NO | |
| RxCUI: 687419 | Fluoromisonidazole (18-F) | Designated preferred name (PT) | NO | |
| RxCUI: 687419 | Fluoromisonidazole (18-F) | Full form of descriptor (FN) | NO | |
| RxCUI: 687423 | norgestimate 0.215 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 687424 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 687424 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 687424 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 687424 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 687424 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 687426 | Product containing lactic acid and sodium pidolate (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687426 | Product containing lactic acid and sodium pidolate (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687428 | Product containing lamivudine and nevirapine and zidovudine (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 687428 | Product containing lamivudine and nevirapine and zidovudine (medicinal product) | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 687428 | Product containing lamivudine and nevirapine and zidovudine (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687428 | Product containing lamivudine and nevirapine and zidovudine (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687431 | Product containing levomenthol and pentane (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687431 | Product containing levomenthol and pentane (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687432 | levothyroxine Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 687441 | tetracaine 70 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 687442 | lidocaine / tetracaine Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 687443 | lidocaine 7 % / tetracaine 7 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 687443 | lidocaine 7 % / tetracaine 7 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 687443 | lidocaine 7 % / tetracaine 7 % Topical Cream | Designated preferred name (PT) | YES | |
| RxCUI: 687443 | lidocaine 7 % / tetracaine 7 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 687443 | lidocaine 7 % / tetracaine 7 % Topical Cream | Full form of descriptor (FN) | YES | |
| RxCUI: 687468 | Product containing cocaine and morphine (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687468 | Product containing cocaine and morphine (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687469 | Product containing morphine and peppermint oil (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687469 | Product containing morphine and peppermint oil (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687475 | Azelastine-containing product in nasal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 687475 | Azelastine-containing product in nasal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 687482 | Ciclesonide-containing product in nasal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 687482 | Ciclesonide-containing product in nasal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 687497 | 9 cis-octadecenoic acid- and oil of turpentine-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 687497 | 9 cis-octadecenoic acid- and oil of turpentine-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 687524 | Product containing phenolphthalein and rhubarb (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687524 | Product containing phenolphthalein and rhubarb (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687528 | Product containing Podophyllum resin and salicylic acid (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687528 | Product containing Podophyllum resin and salicylic acid (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687531 | Product containing potassium chloride and sodium chloride and sodium lactate (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687531 | Product containing potassium chloride and sodium chloride and sodium lactate (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687582 | Product containing timolol and travoprost (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 687582 | Product containing timolol and travoprost (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 687588 | Tyrosinaemia food | British preferred term (PTGB) | NO | |
| RxCUI: 687588 | Tyrosinaemia food | Designated preferred name (PT) | NO | |
| RxCUI: 687588 | Tyrosinaemia food | Full form of descriptor (FN) | NO | |
| RxCUI: 687589 | Clindamycin-containing product in vaginal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 687589 | Clindamycin-containing product in vaginal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 687596 | Wood preservative | Designated preferred name (PT) | NO | |
| RxCUI: 687596 | Wood preservative | Full form of descriptor (FN) | NO | |
| RxCUI: 6876 | methyldopa (levorotatory) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 6876 | methyldopa (levorotatory) | Designated preferred name (PT) | YES | |
| RxCUI: 6876 | methyldopa (levorotatory) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 6876 | methyldopa (levorotatory) | Full form of descriptor (FN) | YES | |
| RxCUI: 6876 | methyldopa (levorotatory) | Designated preferred name (PT) | YES | |
| RxCUI: 6876 | methyldopa (levorotatory) | Full form of descriptor (FN) | YES | |
| RxCUI: 687620 | Benefiber | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 687659 | carbetapentane 4 MG/ML / guaifenesin 20 MG/ML / phenylephrine 2.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 687659 | carbetapentane 4 MG/ML / guaifenesin 20 MG/ML / phenylephrine 2.5 MG/ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 687692 | Creomulsion | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 6877 | Methyldopate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 6877 | Methyldopate | Designated preferred name (PT) | YES | |
| RxCUI: 6877 | Methyldopate | Full form of descriptor (FN) | YES | |
| RxCUI: 687707 | Cyanokit | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 6878 | Methylthioninium chloride-containing product | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 6878 | Methylthioninium chloride-containing product | Designated preferred name (PT) | YES | |
| RxCUI: 6878 | Methylthioninium chloride-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 6878 | Methylthioninium chloride-containing product | Designated preferred name (PT) | YES | |
| RxCUI: 6878 | Methylthioninium chloride-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 6878 | Methylthioninium chloride-containing product | Full form of descriptor (FN) | YES | |
| RxCUI: 6878 | Methylthioninium chloride-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 6878 | Methylthioninium chloride-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 6878 | Methylthioninium chloride-containing product | Full form of descriptor (FN) | YES |